Tag: Dermatologic Surgery

All

Long Shot: Revance’s RT002 May Banish Frown Lines for 7 Months

Revance's investigational injectable—RT002—achieves median duration of 7 months, a phase 2 active comparator study now underway.

Hot Stuff: February 2015
Xeomin Versus Botox Study for Furrows: It’s a Draw
ASDSA Launches Patient Safety Database to Gather Adverse Events During Dermatologic Surgery Procedures
Knowing Your Risk for Skin Cancer May Limit Unhealthy Behaviors

All

Sorry, No Posts Found

All

Are Your Employees About to Quit?

In the first installment of a two-part article series, YellowTelescope President Jon Hoffenberg shares how data can uncover hidden insights in staff retention.

Aesthetic Procedures Risky in Unregulated Offices, Warns Society
ASPS Highlights Commitment to Patient Safety Amid Cosmetic Surgery Concerns
Social Media Use May Help to Empower Plastic Surgery Patients